Narita, Keisuke
Hoshide, Satoshi
Kario, Kazuomi
Article History
Received: 9 February 2021
Revised: 25 April 2021
Accepted: 28 May 2021
First Online: 6 September 2021
Compliance with ethical standards
:
: KK has received research funding from Teijin Pharma Limited, Omron Healthcare Co., Fukuda Denshi, Bayer Yakuhin Ltd., A&D Co., Daiichi Sankyo Co., Mochida Pharmaceutical Co., EA Pharma, Boehringer Ingelheim Japan Inc., Tanabe Mitsubishi Pharma Corp., Shionogi & Co., MSD K.K., Sanwa Kagaku Kenkyusho Co., and Bristol-Myers Squibb K.K., as well as honoraria from Takeda Pharmaceutical Co. and Omron Healthcare Co.